Vascular Neogenesis – Angiogenesis Explained
Vascular neogenesis refers to the formation of new blood vessels in the body. This process is vital for development and healing, but can also drive diseases such as cancer.
Things worth knowing about "Vascular Neogenesis"
Vascular neogenesis refers to the formation of new blood vessels in the body. This process is vital for development and healing, but can also drive diseases such as cancer.
What is Vascular Neogenesis?
Vascular neogenesis is the broad term for the formation of new blood vessels. Medical science distinguishes between two main processes: angiogenesis, in which new vessels sprout from pre-existing capillaries, and vasculogenesis, in which blood vessels are formed de novo from precursor cells called angioblasts. Both processes are fundamental to human development, wound repair, and numerous disease states.
Physiological Importance
In a healthy body, vascular neogenesis is a tightly regulated process. It plays a critical role in the following situations:
- Embryonic development: Formation of the entire cardiovascular system before birth.
- Wound healing: Supply of oxygen and nutrients to damaged tissue through newly formed capillaries.
- Menstrual cycle: Cyclic remodeling of the uterine lining.
- Muscle adaptation: Adjustment of vascular supply in response to increased demand during physical activity.
Causes and Triggering Factors
Vascular neogenesis is controlled by a complex interplay of growth factors and signaling molecules. The most important include:
- VEGF (Vascular Endothelial Growth Factor): The primary driver of new vessel growth, released especially during oxygen deprivation (hypoxia).
- FGF (Fibroblast Growth Factor): Promotes the proliferation and migration of endothelial cells.
- Angiopoietins: Regulate the stabilization and maturation of newly formed vessels.
- Hypoxia: Tissue oxygen deficiency is one of the strongest triggers for vascular neogenesis.
Pathological Vascular Neogenesis
When regulation of vessel formation is disrupted, this process can contribute to the onset or progression of disease:
Tumor Angiogenesis
Beyond a certain size, tumors depend on their own blood supply. Cancer cells secrete large amounts of VEGF and other growth factors to recruit new vessels into the tumor tissue. This tumor angiogenesis supports not only primary tumor growth but also the spread of metastases through the bloodstream.
Other Diseases
- Diabetic Retinopathy: Uncontrolled vessel growth in the retina in patients with diabetes mellitus, potentially leading to blindness.
- Age-Related Macular Degeneration (AMD): Ingrowth of fragile new vessels beneath the retina, resulting in vision loss.
- Psoriasis and Rheumatoid Arthritis: Inflammatory conditions in which excessive vessel formation contributes to tissue damage.
- Cardiac Disease: After a heart attack, insufficient vascular neogenesis can impair regeneration of heart muscle tissue.
Diagnosis
Assessment of vascular neogenesis involves several methods:
- Imaging techniques: Doppler ultrasound, MR angiography, or CT angiography to visualize vascular structures.
- Fluorescence angiography: Used particularly in ophthalmology to identify pathological vessel growth in the retina.
- Histology: Tissue samples (biopsies) can be examined microscopically for the presence of new vessels.
- Biomarkers: Measurement of VEGF levels and other angiogenic factors in the blood.
Treatment
Depending on the clinical context, vascular neogenesis can be deliberately promoted or inhibited:
Inhibition of Vessel Formation (Anti-Angiogenesis)
In cancer therapy and eye disease management, the goal is often to suppress pathological vessel growth:
- Anti-VEGF therapy: Drugs such as bevacizumab (Avastin), ranibizumab, or aflibercept block the VEGF signaling pathway, thereby inhibiting vessel growth. They are used in various cancers as well as in AMD and diabetic retinopathy.
- Tyrosine kinase inhibitors: Agents such as sorafenib or sunitinib inhibit intracellular pathways required for vessel formation.
- Photodynamic therapy: Used in certain eye conditions to destroy abnormal vessels.
Promotion of Vessel Formation (Pro-Angiogenesis)
In regenerative medicine and cardiology, researchers are investigating methods to deliberately stimulate new vessel growth -- for example, following a heart attack or in peripheral arterial disease (PAD). Approaches include the administration of growth factors and the use of stem cells.
References
- Folkman, J. - Angiogenesis: an organizing principle for drug discovery? Nature Reviews Drug Discovery, 2007.
- Carmeliet, P. - Angiogenesis in life, disease and medicine. Nature, 2005.
- World Health Organization (WHO) - Cancer: Key facts and treatment guidelines. WHO, 2023.
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Vascular Neogenesis-en